DWTX: SEC Form S-3 filed by Dogwood Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for DWTX
Across the 20 sessions after earlier DWTX headlines, the stock closed higher 6 times and lower 12 times, with a median move of 5.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DWTX | SPY |
|---|---|---|---|
| Oct 19, 2026 | Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc. | -0.8% | +0.4% |
| Oct 6, 2026 | Dogwood to Participate in the 2026 Maxim Growth Summit | +0.0% | +0.5% |
| Sep 14, 2026 | Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial | -4.9% | -0.4% |
| Aug 17, 2026 | Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026 | -4.2% | -0.5% |
| Aug 13, 2026 | Dogwood Therapeutics Announces Second Quarter 2026 Financial Results | +2.9% | +0.7% |
| Jul 20, 2026 | Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026 | +0.0% | -0.2% |
Quantisnow market dataNASDAQ
DWTX
Dogwood Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for DWTX
Full DWTX profile on Quantisnow Follow DWTX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time